CoChat

Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma

Open access
Sabbatino, F, Favoino, E, Wang, Y, Wang, X, Villani, V, Cai, L, Yang, L, Ferrone, S, Ferrone, CR · 2015 · Journal of Translational Medicine
Cited by 48

The DOI matches its Crossref record.

Abstract

The development of BRAF-I resistance in BRAFV600E \nmelanoma underlies the need to develop strategies to \ncounteract this resistance. It has been shown that administration of heat shock protein 90 (HSP90) inhibitors can \ncounteract multiple mechanisms which drive BRAF-I \nresistance by reactivation of MAPK and activation of \nPI3K/AKT pathway. However the clinical application of \nthis strategy is hampered the high toxicity associated \nwith administration of currently available HSP90 inhibitors. To overcome this limitation we have developed a \nnovel monoclonal antibody (mAb), named W9, which \nrecognizes an extracellular epitope of glucose regulated \nprotein of 94 kDa (Grp94), a member of the HSP90 \nfamily. The mAb W9 defined Grp94-epitope is selectively \nexpressed on malignant cells but is not detectable on \nnormal cells. Therefore targeting Grp94-epitope by mAb \nW9 is expected to cause limited if any side effects. The \nmAb W9 was found to increase and restore the sensitivity to BRAF-I of BRAFV600E melanoma cells including \ncells which have acquired BRAF-I resistance because of \nPDGFRa upregulation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1479-5876-13-s1-k12

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 48

Metadata

Authors
Sabbatino, F., Favoino, E., Wang, Y., Wang, X., Villani, V, Cai, L., Yang, L., Ferrone, S., & Ferrone, C.
Venue
Journal of Translational Medicine
Published
2015-01-15
Volume
13
Issue
S1
ISSN
1479-5876 (ISSN-L)
OpenAlex
W1715905369
Cited by
48
References
0
FWCI
2.44
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma. https://app.cochat.ai/papers/10.1186/1479-5876-13-s1-k12
The paper
Sabbatino, F., Favoino, E., Wang, Y., Wang, X., Villani, V, Cai, L., Yang, L., Ferrone, S., & Ferrone, C. (2015). Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma. Journal of Translational Medicine. https://doi.org/10.1186/1479-5876-13-s1-k12

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.